Venture-Backed Startups

0 investors

BioCorteX develops personalized therapeutics using a microbiome knowledge graph and proprietary biology emulation platform to tailor drug treatments for diverse populations. The company aims to improve treatment efficacy across different communities by accounting for individual microbiome variations in drug development.

1 investor

BioCorteX builds a biology-based knowledge graph of microbiome samples (Carbon Knowledge) and a foundational emulator (Carbon Mirror) that models interactions between bacteria, the human immune system, diseases, and drugs to generate insights for drug discovery and development. Its products serve the pharmaceutical and therapeutics industry.

1 investor

BioCraft produces animal cell-cultured ingredients for pet food manufacturers, offering nutritionally complete, sustainably sourced alternatives to conventional meat with 92% lower carbon emissions. The ingredients provide amino acids, essential fats, vitamins, and minerals while eliminating antibiotics, heavy metals, viruses, and bacteria found in conventional meat.

1 investor

Biocule sells face serums formulated for different skin types, using ECOCERT-certified ingredients and manufactured in a WHO-GMP certified facility. Its skincare products are dermatologically tested.

1 investor

0 investors

0 investors

0 investors

BioCytics conducts translational cancer research, including a project with UNC Charlotte and Carolina BioOncology Institute to study the "dark genome" of cancer cells to identify sequences involved in tumor growth, immune response, and treatment response. Its work spans cell therapy, neoantigens, tumor infiltrating lymphocytes, and clinical research informatics.

0 investors

Biocytogen (HKEX: 02315) is a global biotechnology company that uses genetically engineered mouse models and its RenMice/RenMab/RenNano fully human antibody platforms to develop therapeutic antibody drugs. It provides antibody discovery, humanized mouse models (e.g. B-NDG, immune checkpoint humanized mice), and preclinical pharmacology and CRO services to biopharma clients worldwide.

1 investor

Biodata Bank develops Canaria+, a wearable wrist device that detects rising internal body temperature and warns workers of heat-related risks through sound, light, and vibration alarms without requiring charging, connectivity, or setup. It is aimed at companies protecting field and industrial workers from heatstroke, and the reusable devices are collected and refurbished to reduce waste.

1 investor

0 investors

Bio Design Lab develops biopharmaceuticals using synthetic biology and systems-level genetic and genomic design. Its initial focus is advancing retroviral and lentiviral vector platforms that serve as foundational technologies for cell and gene therapies.

1 investor

0 investors

0 investors

BioDit offers biometric security solutions, including wireless and wired systems for access control and identity verification.

2 investors

Biodiversity Intelligence measures and monitors biodiversity by combining eDNA sampling of soil and water, satellite and SAR remote sensing, climate data, and deep learning to produce standardized nature indices and indicators. It targets nature-market and land-use project operators, supporting nature disclosure, certification, and nature-based solutions through an interactive monitoring dashboard.

1 investor

Biodock provides an AI image analysis platform designed for researchers and scientists to train, run, and interpret deep learning models on biological images without requiring coding expertise. The platform enables rapid model creation, distributed execution at scale, and detailed quantitative analysis for research organizations in biotech and life sciences.

3 investors

Biodol Therapeutics is a biotech company developing proprietary FLT3 inhibitors (BDT compounds) at the preclinical stage to treat neuropathic and chronic pain, including opioid-combination indications. It holds a portfolio of patents covering the use of FLT3 inhibitors for pain treatment.

1 investor

Provides technologies for detection, neutralization, and removal of endotoxin for bioresearch and bioprocess markets.

1 investor

Biodynamik is a medical device company developing orthopedic-driven regenerative technologies, including its XT3 System for treating diabetic foot ulcers. The company is pursuing U.S. clinical trials under FDA IDE approval.

0 investors

BioEclipse Therapeutics is a clinical-stage oncology company developing immuno-oncology therapeutics using a proprietary platform that targets the tumor microenvironment through engineered immune cell therapies. The company's approach combines multiple mechanisms of action to eradicate cancer cells and generate durable immune responses against relapse and recurrence.

2 investors

BioEsol provides industrial and commercial energy management software and Energy as a Service (EaaS) solutions, optimizing energy consumption and incorporating battery energy storage systems (BESS) for businesses seeking to reduce operational energy costs and carbon emissions.

1 investor

Bio Eutectics develops Natural Deep Eutectic Systems, bio-sourced solvents made from natural acids, amino acids, alcohols, and sugars to replace petrochemical solvents in industrial processes. It customizes these green chemistry solutions for manufacturers across industries seeking lower-toxicity, lower-volatility alternatives.

3 investors